This study looks at how well a medicine called KarXT works to prevent relapse in people with schizophrenia, a mental health condition that affects thinking and behavior. To join, you must have had schizophrenia for at least a year and been in the hospital for it in the last year. You also need to have certain symptoms, measured by tests like PANSS (Positive and Negative Syndrome Scale) and CGI-S (Clinical Global Impression-Severity). PANSS and CGI-S are scales that help doctors understand how severe your symptoms are. You cannot join if you have another mental disorder, certain risks like suicidal thoughts, or if your symptoms improved too much before the study.

• The study requires multiple visits to the study site.
• You may receive compensation for participating.
• There may be risks or side effects from the treatment.